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Abstract  
Introduction: Adenosquamous carcinoma (ASC) of lung is a rare and poorly described subtype of bronchogenic carcinoma. Most 
patients of adenosquamous carcinoma of lung come from older age group and present with cough, chest pain, weight loss, dyspnoea, 
haemoptysis, and fatigue. The radiologic findings of adenosquamous lung carcinoma may consist typically a peripheral solitary nodule 
or less commonly a central hilar mass. Here we present a unique case of adenosquamous lung carcinoma in a young adult who 
presented with nonspecific complaints and unusual chest X ray along with atypical findings on contrast enhanced computerised 
tomography in the form of necrotising mediastinal lymphadenopathy.  
Presentation of Case: A 30 years old male non-smoker and non-alcoholic office worker presented at with nonspecific symptoms of 
dry cough and exertional dyspnoea. Physical examination revealed a single, hard, non-tender lymph node in right supraclavicular 
region which on excisional biopsy and histopathology revealed poorly differentiated metastatic adenosquamouscarcinoma confirmed 
by immunohistochemistry. Chest skiagram PA view showed bilateral nodular shadows in mid and lower zones and right paratracheal 
opacity. CECT thorax revealed multiple mediastinal lymph nodes with hypo areas suggestive of internal necrosis. In spite of adequate 
anticancer chemotherapy regimen, clinico-radiological deterioration was observed. 
Conclusion: Adenosquamous carcinomas usually presents in advanced stage, show an aggressive histologic behaviour with poor 
survival rates than the single histology group. Early identification of such cases with varied presentation may save lives. Keeping these 
things in mind, early identification of such cases with varied presentation may improve survival to some extent.  
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Introduction 
Adenosquamous cancers (ASC) is not a common variant of lung malignancy and found only in 
0.4–4.2% of patients diagnosed as primary lung cancers [1-3]. Clinicoradiological characteristics of 
ASC are still not clearly defined. ASC are commonly found in men, who have a history of smoking. 
It is disease of old population usually presenting in sixth or seventh decade of their life  [4, 5].
  
Major symptoms associated with ASC are cough, chest pain and dyspnoea. Other symptoms may 
include haemoptysis, fever and weight loss. The tumour does not present with any specific 
radiological pattern but majority of the tumours are peripherally located and are more common on the 
right side than the left [4, 6].
 
There may be wide imaging spectrum both in terms of size and 
morphology [6]. It is difficult to distinguish ASC from other histological forms on basis of imaging 
studies. These patients usually presents as a single lesion on chest x ray and mean tumour size may 
range between 2.8 - 3.8cm (range 0.6 - 11cm )
 [6,7]  
CT radiographic includes usually a peripherally 
located mass with lobulation and/or intra-tumoral necrosis within the tumour [7].
 
There is also an increased incidence of lymph node metastases at the time of initial presentation 
compared with other histological types [8]. Mediastinal lymph node enlargement is found in more 
than half of cases of ASC [5].
 
Lymph node may enlarge at multiple mediastinal stations in these cases. 
There may be heterogeneous contrast enhancement of lymph nodes but no internal necrosis. 
Necrotising lymphadenopathy has been reported in squamous variety of lung cancer but it has not 
been reported in ASC.  
To the best of our knowledge this is first ever reported case of adenosquamous carcinoma 
presenting with necrotic mediastinal lymph nodes in a non-smoker young adult, a very rare 
presentation of the disease, along with its review of literature. Other causes of necrotising 
lymphadenopathy were ruled out e.g. vascular compromise from vasculitis; occlusion or trauma; post 
mediastinoscopy, infections as  tuberculosis, fungal infections and as well as malignant diseases 
like lymphoma and metastatic lesion primarily in squamous cell carcinoma.   
Case presentation 
A 30 years old male presented at the outpatient department with nonspecific symptoms of dry cough 
and exertional dyspnoea for 3 months. There were no complaints of haemoptysis and hoarseness of 
voice or constitutional symptoms like fever, loss of appetite and weight loss. The patient denied any 
history of trauma or drug intake, any operative procedure. He was a non-smoker and non-alcoholic 
office worker.  
On physical examination, respiratory rate was 20/min, pulse rate was 112/min and blood pressure 
was 126/76 mm Hg. He was afebrile. A single, 1 cmx1cm, hard, non-tender lymph node in right 
supraclavicular region was noted that was fixed to underlying structures. Clubbing, cyanosis, dilated 
veins, pedal oedema and any organomegaly were absent. Respiratory system examination revealed 
bilateral inspiratory crackles in both infra-scapular regions. Examination of other systems revealed 
nothing abnormal. 
Laboratory investigations revealed normal total and differential white cell counts but haemoglobin 
was 9 gm% and ESR was 20 mm first hour. Fasting blood sugar, renal function tests and liver 
function tests were within normal limits. HIV serology was negative. Sputum smear examination for 
AFB was negative. Pulmonary Function Tests and ECG were within normal limits. Ultra-sonography 
of abdomen revealed nothing abnormal. Chest skiagram PA view showed bilateral nodular shadows 
in mid and lower zones and right paratracheal opacity (Fig 1). Contrast Enhanced CT revealed 
para-tracheal, pre-aortic and pre-carinal lymph nodes. All the lymph nodes showed hypo dense 
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lesions suggestive of internal necrosis (Fig 2.A &B). Peri-bronchovascular thickening and septal 
thickening were also present. 
 
 
Figure 1 Chest skiagram PA view showing bilateral mid and lower zone nodular shadows and right para-tracheal 
opacity. 
 
 
 
 
 
 
 
Figure 2 (A, B) CECT of Thorax showing necrotising lymph nodes. (A). Right para-tracheal and pre-tracheal (B). 
Right para-aortic, pre-carinal and left para hilar. 
A B 
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Figure 3 Squamous cell element in ADC carcinoma with keratinization and intracellular bridges. 
 
Figure 4 Bone scan showing foci of increased tracer uptake (MDP) in vertebra (cervical and lumber), multiple ribs 
(3
rd
 and 6
th
) and pelvis suggestive of bone metastasis. 
FNAC of the right supra-clavicular lymph node showed few lymphocytes and macrophages but it 
was negative for malignancy or tuberculosis. Excisional biopsy and histopathology of the lymph 
node revealed poorly differentiated metastatic adenocarcinoma. However, marker studies confirmed 
it to be Adenosquamous carcinoma as the specimen was positive for CK-7, TTF-1 and P-63 and 
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negative for CK-20 markers. Review of the histopathology slides unrevealed the squamous 
component of the tumour as well (Fig 3). Bone scan showed foci of increased tracer uptake (MDP) in 
vertebra (cervical and lumber), multiple ribs (3
rd
 and 6
th
) and pelvis suggestive of bone metastasis 
(Fig 4). 
 In spite of adequate anticancer chemotherapy regimen, clinico-radiological deterioration was 
observed in follow up visits. 
Discussion 
Non-small cell lung carcinoma (NSCLC) comprises about 80 percent of all lung cancers  [9]. In spite 
of improvements in diagnostic technologies, more than 50% of the patients present with locally 
advanced or distant metastatic disease and the prognosis still remains unsatisfactory [10,11].
 
Adenosquamous carcinoma (ASC) of the lung comprises a rare variant, comprising about 0.4-4% 
of the lung carcinomas [12-14]
 
but poor phenotypic characterization, specifically with regard to 
minor phenotypes, such as adenosquamous carcinoma(ASC) [15] and large cell neuroendocrine 
carcinoma[16]; may contribute to under diagnosis of the tumour. 
Adenosquamous carcinomas show both the squamous and the adenocarcinomatous differentiation, 
each component constituting at least 10% of the tumour (also known as “collison tumour”)  [17]. The 
areas of glandular and squamous differentiation may be located in different areas of the tumour or 
may be intimately admixed [18]. Most of these tumours are peripheral.  
Diagnosis of the tumour is usually established by direct FNAC of the peripherally situated lung 
mass/lymph node or by an interventional procedure but biopsy is required for tissue differentiation. 
Further confirmation of ASC tumour type requires immune-marker studies [6,7]which may be 
positive for P 63, AE 1/AE 3, Cam 5.2, KL 1, CK 7, EMA &/or TTF-1 but negative for CK 20. In our 
case, it was positive for CK-7, TTF-1 and P-63 but was negative for CK-20. 
ASC is more aggressive than other histologic subtypes of bronchogenic carcinomas and the 
median survival started from diagnosis to treatment is shorter as compared to adenocarcinoma, 
squamous and small cell lung cancer [2].
 
Metastasis is common despite good differentiation. 
Depending on staging, it is treated with anti-tumour chemotherapy or surgically resected. In a study 
of 56 patients by Takamori et al, the authors suggested that adenosquamous carcinoma histology was 
in itself a single and independent predictor of poor outcome at all stages, especially for stage I and II 
[3]. Ruffini et al also observed that the overall prognosis is inferior to that for either squamous cell 
carcinoma or adenocarcinoma because of a high rate of early metastatic spreading [19]. Five year 
survival in 172 patients who underwent resection was 45% in squamous cell carcinoma, 27% in 
adenocarcinoma and 26% in large cell carcinoma. Of the 13 patients (4%) with adenosquamous 
carcinoma, none survived for five years after surgical treatment [20].
 
Our patient was unfit for 
surgery and was unresponsive to chemotherapy. 
Conclusions 
Lung tumours with mixed histologic pattern are a rare occurrence. Adenosquamous carcinomas have 
progressed to advanced stages at presentation in most of patients, show an aggressive histologic 
behaviour, and have survival rates significantly lower than the single histology group. One should 
keep these things in mind while dealing such patients with mixed histology patterns. Early 
identification of such cases with varied presentation may improve survival to some extent. 
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